US Stock MarketDetailed Quotes
SPRB Spruce Biosciences
- 0.483
- -0.008-1.57%
Close Nov 22 16:00 ET
- 0.483
- 0.000-0.06%
Post 20:01 ET
19.96MMarket Cap-508P/E (TTM)
0.520High0.480Low190.53KVolume0.481Open0.491Pre Close93.89KTurnover0.80%Turnover RatioLossP/E (Static)41.30MShares5.95052wk High0.39P/B11.48MFloat Cap0.41152wk Low--Dividend TTM23.74MShs Float35.600Historical High--Div YieldTTM8.09%Amplitude0.411Historical Low0.492Avg Price1Lot Size
Spruce Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 24.83%-9.22M | -657.25%-11.11M | -26.87%-14.96M | 20.17%-33.28M | 4.51%-11.21M | -43.03%-12.27M | 120.89%1.99M | 0.30%-11.79M | -16.18%-41.68M | -19.79%-11.74M |
| Net income from continuing operations | 29.81%-8.67M | 28.41%-9.18M | 9.12%-11.63M | -3.77%-47.92M | 10.71%-9.95M | -8.36%-12.35M | -8.01%-12.82M | -8.75%-12.79M | -9.19%-46.18M | -21.34%-11.14M |
| Operating gains losses | --0 | ---- | ---- | -94.87%2K | --0 | --0 | --0 | --2K | --39K | ---- |
| Depreciation and amortization | -41.18%10K | -33.33%12K | -21.05%15K | -5.41%70K | -33.33%16K | -26.09%17K | 200.00%18K | -9.52%19K | 8.82%74K | 20.00%24K |
| Other non cash items | 112.09%62K | -74.48%61K | 148.00%60K | 158.23%230K | 197.52%629K | -710.71%-513K | 184.52%239K | -252.44%-125K | -226.20%-395K | -906.25%-645K |
| Change In working capital | -81.29%-1.76M | -126.76%-3.69M | -11,144.44%-4.97M | 814.84%10.36M | -245.21%-2.49M | -150.36%-973K | 971.83%13.77M | 103.30%45K | -42.10%1.13M | 54.16%-721K |
| -Change in receivables | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---15M | ---- | ---- |
| -Change in prepaid assets | 377.97%1.13M | 1,940.00%918K | -128.77%-191K | -222.64%-2.64M | -274.19%-3.58M | -44.47%236K | -91.62%45K | 180.78%664K | -296.87%-817K | 27.66%-957K |
| -Change in payables and accrued expense | -215.32%-2.24M | -410.15%-2.93M | -327.42%-2.8M | 272.65%8.16M | 1,139.57%4.04M | 25.16%1.95M | 16.22%946K | 343.85%1.23M | 46.10%2.19M | 228.35%326K |
| -Change in other current assets | 134.29%12K | 91.67%-1K | -52.87%74K | 6.67%96K | -216.67%-14K | -168.63%-35K | ---12K | 481.48%157K | -54.31%90K | -81.82%12K |
| -Change in other current liabilities | -30.43%-60K | -41.46%-58K | -34.15%-55K | 46.83%-176K | 52.94%-48K | 53.06%-46K | 37.88%-41K | 36.92%-41K | -112.18%-331K | -64.52%-102K |
| -Change in other working capital | 80.44%-601K | 25.64%-1.61M | -115.37%-2M | --4.91M | ---2.89M | ---3.07M | ---2.17M | --13.04M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 24.83%-9.22M | -657.25%-11.11M | -26.87%-14.96M | 20.17%-33.28M | 4.51%-11.21M | -43.03%-12.27M | 120.89%1.99M | 0.30%-11.79M | -16.18%-41.68M | -19.79%-11.74M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 135.43%55.78M | -36.17%9.3M | 182.83%13.99M | -34.34%22M | 239.95%10.48M | 129.93%23.69M | 343.51%14.57M |
| Net PPE purchase and sale | ---- | ---- | ---- | 12.50%-7K | --0 | ---- | ---- | ---- | 91.40%-8K | --0 |
| Net investment purchase and sale | --0 | --0 | --0 | 135.38%55.78M | -36.17%9.3M | 182.88%14M | -34.35%22M | 239.95%10.48M | 129.97%23.7M | 343.75%14.57M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 135.43%55.78M | -36.17%9.3M | 182.83%13.99M | -34.34%22M | 239.95%10.48M | 129.93%23.69M | 343.51%14.57M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0.00%-405K | 15.51%-365K | -100.45%-227K | 20,490.04%49.14M | -1,633.33%-552K | -350.00%-405K | -336.36%-432K | 57,519.32%50.53M | -137.48%-241K | -78.44%36K |
| Net issuance payments of debt | 0.00%-405K | 0.00%-406K | 0.00%-405K | ---1.62M | ---406K | ---405K | ---406K | ---405K | --0 | --0 |
| Net common stock issuance | --0 | --0 | --0 | --53.62M | --0 | --0 | --0 | --53.62M | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | -51.40%52K | --180K | 128.21%178K | 86.84%71K | --0 | 181.58%107K | --0 | -83.12%78K | -81.55%38K |
| Net other financing activities | --0 | 91.73%-11K | 99.93%-2K | -850.47%-3.03M | -10,750.00%-217K | --0 | 2.92%-133K | -2,880.00%-2.68M | -717.95%-319K | ---2K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 0.00%-405K | 15.51%-365K | -100.45%-227K | 20,490.04%49.14M | -1,633.33%-552K | -350.00%-405K | -336.36%-432K | 57,519.32%50.53M | -137.48%-241K | -78.44%36K |
| Net cash flow | ||||||||||
| Beginning cash position | -28.51%69.72M | 9.78%81.19M | 289.67%96.37M | -42.44%24.73M | 352.02%98.84M | 105.62%97.52M | 213.91%73.96M | -42.44%24.73M | -72.70%42.96M | -62.67%21.87M |
| Current changes in cash | -829.95%-9.63M | -148.69%-11.47M | -130.85%-15.19M | 492.95%71.64M | -185.84%-2.46M | 105.16%1.32M | -1.28%23.56M | 353.66%49.22M | 84.06%-18.23M | 118.36%2.87M |
| End cash Position | -39.20%60.09M | -28.51%69.72M | 9.78%81.19M | 289.67%96.37M | 289.67%96.37M | 352.02%98.84M | 105.62%97.52M | 213.91%73.96M | -42.44%24.73M | -42.44%24.73M |
| Free cash flow | 24.87%-9.22M | -657.25%-11.11M | -26.87%-14.96M | 20.17%-33.28M | 4.51%-11.21M | -43.08%-12.28M | 120.88%1.99M | 0.30%-11.79M | -15.90%-41.69M | -19.71%-11.74M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data